A prospective cohort study further demonstrated that T2DM patients with elevated fasting insulin levels and higher homeostasis model assessment of insulin resistance (HOMA-IR) scores have a significantly increased incidence of OSA (Huang et al., 2022). This evidence concerns the gene INS and Insulin resistance.